Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2019

Open Access 01-12-2019 | Idiopathic Pulmonary Fibrosis | Research article

IPF patients are limited by mechanical and not pulmonary-vascular factors – results of a derivation-validation cohort study

Authors: Benjamin D. Fox, Yael Shostak, Barak Pertzov, Baruch Vainshelboim, Shimon Itzhakian, Irit Terner, Mordechai R. Kramer

Published in: BMC Pulmonary Medicine | Issue 1/2019

Login to get access

Abstract

Background

During cardiopulmonary exercise testing (CPET), Idiopathic Pulmonary Fibrosis (IPF) patients do not reach their direct maximum voluntary ventilation (MVV) and have deranged gas exchange. Their exercise limitation is therefore attributed to a pulmonary vascular mechanism.

Methods

We studied two cohorts (derivation and validation) of IPF patients with lung function testing and CPET. Maximal ventilation at exercise (VEpeak) was compared to direct MVV by Bland-Altman analysis.

Results

In the derivation cohort (n = 101), direct MVV over-estimated VEpeak by a factor of 1.51, driven by respiratory rate during MVV that was 1.99 times higher at rest as compared to VEpeak at exercise. The formula (FEV1 × 20.1) + 15.4 was shown to predict VEpeak (r2 = 0.56) in the derivation cohort. In the validation cohort of 78 patients, VEpeak was within a factor of 1.27 (6.8 l/min) of predicted according to the novel formula. According to the novel prediction formula the majority of patients (58%) in the entire cohort have VEpeak within 85% of their predicted MVV, which would indicate a mechanical respiratory limitation to exercise.

Conclusion

Estimation of direct MVV performed at rest leads to significant over-estimation of the breathing reserve in IPF patients. This may lead to over-diagnosis of pulmonary vascular limitation in these patients. Expected maximal ventilation at exercise may be accurately predicted indirectly by an IPF-specific formula.
Literature
1.
go back to reference Raghu G, Rochwerg B, Zhang Y, et al. An official ATS/ERS/JRS/ALAT Cinical practice guideline:treatment of idiopathic pulmonary fibrosis. An update of the 2011 clinical practice guideline. Am J Respir Crit Care Med. 2015;192:e3–19.CrossRef Raghu G, Rochwerg B, Zhang Y, et al. An official ATS/ERS/JRS/ALAT Cinical practice guideline:treatment of idiopathic pulmonary fibrosis. An update of the 2011 clinical practice guideline. Am J Respir Crit Care Med. 2015;192:e3–19.CrossRef
2.
go back to reference Rusanov V, Shitrit D, Fox B, et al. Use of the 15-steps climbing exercise oximetry test in patients with idiopathic pulmonary fibrosis. Respir Med. 2008;102:1080–8.CrossRef Rusanov V, Shitrit D, Fox B, et al. Use of the 15-steps climbing exercise oximetry test in patients with idiopathic pulmonary fibrosis. Respir Med. 2008;102:1080–8.CrossRef
3.
go back to reference Wasserman K, Hansen JE, Sue DY, et al. Principles of exercise testing and interpretation. 4th ed. Philadelphia: Lippincott Williams and Wilkins; 2005. Wasserman K, Hansen JE, Sue DY, et al. Principles of exercise testing and interpretation. 4th ed. Philadelphia: Lippincott Williams and Wilkins; 2005.
4.
go back to reference American Thoracic Society and American College of Chest Physicians. ATS/ACCP statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med. 2003;167:211–77.CrossRef American Thoracic Society and American College of Chest Physicians. ATS/ACCP statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med. 2003;167:211–77.CrossRef
5.
go back to reference Carlson DJ, Ries AL, Kaplan RM. Prediction of maximum exercise tolerance in patients with COPD. Chest. 1991;100:307–11.CrossRef Carlson DJ, Ries AL, Kaplan RM. Prediction of maximum exercise tolerance in patients with COPD. Chest. 1991;100:307–11.CrossRef
6.
go back to reference Carter R, Peavler M, Zinkgraf S, et al. Predicting maximal exercise ventilation in patients with chronic obstructive pulmonary disease. Chest. 1987;92:253–9.CrossRef Carter R, Peavler M, Zinkgraf S, et al. Predicting maximal exercise ventilation in patients with chronic obstructive pulmonary disease. Chest. 1987;92:253–9.CrossRef
8.
go back to reference Hansen JE, Sue DY, Wasserman K. Predicted values for clinical exercise testing. Am Rev Respir Dis. 1984;129:S49–55.CrossRef Hansen JE, Sue DY, Wasserman K. Predicted values for clinical exercise testing. Am Rev Respir Dis. 1984;129:S49–55.CrossRef
9.
go back to reference Mohan-Kumar T, Gimenez M. Maximal ventilation at rest and exercise in patients with chronic pulmonary disease. Respiration. 1984;46:291–302.CrossRef Mohan-Kumar T, Gimenez M. Maximal ventilation at rest and exercise in patients with chronic pulmonary disease. Respiration. 1984;46:291–302.CrossRef
10.
go back to reference Hansen JE, Wasserman K. Pathophysiology of activity limitation in patients with interstitial lung disease. Chest. 1996;109:1566–76.CrossRef Hansen JE, Wasserman K. Pathophysiology of activity limitation in patients with interstitial lung disease. Chest. 1996;109:1566–76.CrossRef
12.
go back to reference Hayes DJ, Black SM, Tobias JD, et al. Influence of pulmonary hypertension on patients with idiopathic pulmonary fibrosis awaiting lung transplantation. Ann Thorac Surg. 2016;101:246–52.CrossRef Hayes DJ, Black SM, Tobias JD, et al. Influence of pulmonary hypertension on patients with idiopathic pulmonary fibrosis awaiting lung transplantation. Ann Thorac Surg. 2016;101:246–52.CrossRef
13.
go back to reference Harari S, Caminati A, Cassandro R, et al. Pulmonary hypertension in idiopathic pulmonary fibrosis does not influence six-minute walk distance:results from a retrospective study. Sarcoidosis Vasc Diffuse Lung Dis. 2015;31:297–305.PubMed Harari S, Caminati A, Cassandro R, et al. Pulmonary hypertension in idiopathic pulmonary fibrosis does not influence six-minute walk distance:results from a retrospective study. Sarcoidosis Vasc Diffuse Lung Dis. 2015;31:297–305.PubMed
14.
go back to reference Degani-Costa LH, Levarge B, Digumarthy SR, et al. Pulmonary vascular response patterns during exercise in interstitial lung disease. Eur Respir J. 2015;46:738–49.CrossRef Degani-Costa LH, Levarge B, Digumarthy SR, et al. Pulmonary vascular response patterns during exercise in interstitial lung disease. Eur Respir J. 2015;46:738–49.CrossRef
15.
go back to reference Glaser S, Obst A, Koch B, et al. Pulmonary hypertension in patients with idiopathic pulmonary fibrosis - the predictive value of exercise capacity and gas exchange efficiency. PLoS One. 2013;8:e65643.CrossRef Glaser S, Obst A, Koch B, et al. Pulmonary hypertension in patients with idiopathic pulmonary fibrosis - the predictive value of exercise capacity and gas exchange efficiency. PLoS One. 2013;8:e65643.CrossRef
16.
go back to reference Boutou AK, Pitsiou GG, Trigonis I, et al. Exercise capacity in idiopathic pulmonary fibrosis:the effect of pulmonary hypertension. Respirology. 2011;16:451–8.CrossRef Boutou AK, Pitsiou GG, Trigonis I, et al. Exercise capacity in idiopathic pulmonary fibrosis:the effect of pulmonary hypertension. Respirology. 2011;16:451–8.CrossRef
17.
go back to reference Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26:319–38.CrossRef Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26:319–38.CrossRef
18.
go back to reference Macintyre N, Crapo R, Viegi G, et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J. 2005;26:720–35.CrossRef Macintyre N, Crapo R, Viegi G, et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J. 2005;26:720–35.CrossRef
19.
go back to reference Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat Methods Med Res. 1999;8:135–60.CrossRef Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat Methods Med Res. 1999;8:135–60.CrossRef
21.
go back to reference Chemla D, Humbert M, Sitbon O, et al. Systolic and mean pulmonary artery pressures:are they interchangeable in patients with pulmonary hypertension? Chest. 2015;147:943–50.CrossRef Chemla D, Humbert M, Sitbon O, et al. Systolic and mean pulmonary artery pressures:are they interchangeable in patients with pulmonary hypertension? Chest. 2015;147:943–50.CrossRef
23.
go back to reference Yasunobu Y, Oudiz RJ, Sun XG, et al. End-tidal PCO2 abnormality and exercise limitation in patients with primary pulmonary hypertension. Chest. 2005;127:1637–46.CrossRef Yasunobu Y, Oudiz RJ, Sun XG, et al. End-tidal PCO2 abnormality and exercise limitation in patients with primary pulmonary hypertension. Chest. 2005;127:1637–46.CrossRef
24.
go back to reference Marciniuk DD, Watts RE, Gallagher C. Dead space loading and exercise limitation in patients with interstitial lung disease. Chest. 1994;105:183–9.CrossRef Marciniuk DD, Watts RE, Gallagher C. Dead space loading and exercise limitation in patients with interstitial lung disease. Chest. 1994;105:183–9.CrossRef
25.
go back to reference Elia D, Kelly JL, Martolini D, et al. Respiratory muscle fatigue following exercise in patients with interstitial lung disease. Respiration. 2013;85:220–7.CrossRef Elia D, Kelly JL, Martolini D, et al. Respiratory muscle fatigue following exercise in patients with interstitial lung disease. Respiration. 2013;85:220–7.CrossRef
26.
go back to reference Burton JGW, Killian KJ, Jones NL. Pattern of breathing during exercise in patients with interstitial lung disease. Thorax. 1983;38:778–84.CrossRef Burton JGW, Killian KJ, Jones NL. Pattern of breathing during exercise in patients with interstitial lung disease. Thorax. 1983;38:778–84.CrossRef
Metadata
Title
IPF patients are limited by mechanical and not pulmonary-vascular factors – results of a derivation-validation cohort study
Authors
Benjamin D. Fox
Yael Shostak
Barak Pertzov
Baruch Vainshelboim
Shimon Itzhakian
Irit Terner
Mordechai R. Kramer
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2019
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/s12890-019-1015-3

Other articles of this Issue 1/2019

BMC Pulmonary Medicine 1/2019 Go to the issue